Skip to main content
Clinical Trials/NCT07083791
NCT07083791Not yet recruitingNot Applicable

AI-ECG Accessory Pathway Localisation Study

Imperial College London1 site in 1 country100 target enrollmentStarted: August 1, 2025Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
100
Locations
1
Primary Endpoint
Performance and accuracy of the AI-ECG accessory pathway localisation algorithm

Study Overview

Brief Summary

This study seeks to validate the real-world accuracy of an AI-based algorithm for identifying the location of an accessory pathway from the 12-lead electrocardiogram

Detailed Description

Silent validation study of an AI-ECG (artificial intelligence applied to electrocardiography) accessory pathway localisation algorithm, applied to prospective and consecutive cases in clinical practice, to determine its true accuracy and performance.

A pre-existing AI-ECG algorithm will be applied to participant ECG data, collected at the time of their clinical electrophysiology study (EPS) for ablation of their accessory pathway. This will be compared to the ground truth of the successful ablation location, determined by fluoroscopy and/or 3D electroanatomical mapping from their procedure.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
13 Years to 100 Years (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Referred for EPS procedure as part of their clinical care, with a finding of pre-excitation on their ECG
  • Manifest pre-excitation on their ECG any time prior to their procedure
  • Able to give consent
  • Minimum age 13 years old
  • Maximum age 100 years old

Exclusion Criteria

  • Unable to give consent
  • Adults > 100 years old
  • Children < 13 years old
  • Patients with known location of their accessory pathway from a previous EP study

Outcomes

Primary Outcomes

Performance and accuracy of the AI-ECG accessory pathway localisation algorithm

Time Frame: At completion of recruitment, anticipated at 18 months

Performance metrics of the AI-ECG accessory pathway localisation algorithm, including accuracy, F1-score, sensitivity, specificity, positive and negative predictive values. Benchmarked against the ground truth of human operator assessment from fluoroscopy and/or 3D electroanatomical mapping.

Secondary Outcomes

  • Accuracy of the ground truth locations from the human operator compared to the successful ablation location(At completion of recruitment, anticipated at 18 months)
  • Relative performance of the AI-ECG algorithm compared to human estimation(At completion of recruitment, anticipated at 18 months)
  • Relative performance of the AI-ECG algorithm compared to manual localisation algorithms(At completion of recruitment, anticipated at 18 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials